Letters to the Editor
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Monoclonal gammopathy of neurological significance: a case report and a novel approach
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: February 18, 2025
Accepted: April 4, 2025
Accepted: April 4, 2025
970
Views
732
Downloads
132
HTML
Authors
There is increasing evidence regarding gammopathy of clinical significance (MGCS), conditions in which there is paraprotein-mediated tissue and organ damage via mechanisms independent of tumor growth. There is no standard treatment for these novel entities. We describe a case of a 61 years old male presenting with a monoclonal gammopathy of neurological significance (MGNS) treated with four weekly doses of Rituximab (RTX), without benefit, and then with a novel protocol.
Downloads
Download data is not yet available.
Citations
How to Cite
“Monoclonal gammopathy of neurological significance: a case report and a novel approach” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025034. doi:10.4084/MJHID.2025.034.
Copyright (c) 2025 Mario Biglietto, Martina Gherardini, Raffaele Maglione, Azzurra Anna Romeo, Luciano Fiori, Piera Giovangrossi, Alessandro Pulsoni, Ugo Coppetelli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
